This inclusion serves as a benchmark for investors prioritizing sustainable business practices within the pharmaceutical sector. Dr. Steve Yang, Co-CEO and Chairman of the company’s Sustainability Committee, noted that the ranking reflects capital market confidence in their management framework. Beyond the FTSE index, the company currently maintains an AAA rating from MSCI and holds a Gold medal status from EcoVadis.
Operational sustainability remains a core focus for the organization as it expands its footprint across Asia, Europe, and North America. The company has secured validation for its greenhouse gas reduction targets from the Science Based Targets initiative and continues to participate in the United Nations Global Compact. By integrating these standards into its end-to-end development platform, the firm aims to align its internal operations with the values of its partners across more than 30 countries.

Comments (0)
No comments yet. Be the first!